BP1 transcriptionally activates bcl-2 and inhibits TNFα-induced cell death in MCF7 breast cancer cells

Breast Cancer Research

Volumn 9, Issue 5, 2007, Pages

  Stevenson, Holly S ^a   Fu, Sidney W ^b   Pinzone, Joseph J ^c,d   Rheey, Jinguen ^b   Simmens, Samuel J ^b   Berg, Patricia E ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA PROTEIN 1; CASPASE 7; CASPASE 8; CASPASE 9; HOMEODOMAIN PROTEIN; LIPOCORTIN 5; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 8; PROTEIN BCL 2; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASPASE; DLX4 PROTEIN, HUMAN; LUCIFERASE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; WESTERN BLOTTING; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION;

ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36549064681     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1766     Document Type: Article

References (32)

1. Cillo C Cantile M Faiella A Boncinelli E Homeobox genes in normal and malignant cells J Cell Physiol 2001, 188:161-169. 10.1002/jcp.1115 11424082
2. Grier DG Thompson A Kwasniewska A McGonigle GJ Halliday HL Lappin TR The pathophysiology of HOX genes and their role in cancer J Pathol 2005, 205:154-171. 10.1002/path.1710 15643670
3. Care A Felicetti F Meccia E Bottero L Parenza M Stoppacciaro A Peschle C Colombo MP HOXB7: A key factor for tumor-associated angiogenic switch Cancer Res 2001, 61:6532-6539. 11522651
4. Chu MC Selam FB Taylor HS HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells Cancer Biol Ther 2004, 3:568-572. 15044858
5. Coletta RD Christensen K Reichenberger KJ Lamb J Micomonaco D Huang L Wolf DM Muller-Tidow C Golub TR Kawakami K The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1 Proc Natl Acad Sci USA 2004, 101:6478-6483. 404070 15123840 10.1073/pnas.0401139101
6. Raman V Martensen SA Reisman D Evron E Odenwald WF Jaffee E Marks J Sukumar S Compromised HOXA5 function can limit p53 expression in human breast tumors Nature 2000, 405:974-978. 10.1038/35016125 10879542
7. Zhang X Zhu T Chen Y Mertani HC Lee KO Lobie PE Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene J Biol Chem 2003, 278:7580-7590. 10.1074/jbc.M212050200 12482855
8. Chase MB Fu S Haga SB Davenport G Stevenson H Do K Morgan D Mah AL Berg PE BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene Mol Cell Biol 2002, 22:2505-2514. 133721 11909945 10.1128/MCB.22.8.2505-2514.2002
9. Fu S Stevenson H Strovel JW Haga SB Stamberg J Do K Berg PE Distinct functions of two isoforms of a homeobox gene, BP1, and DLX7, in the regulation of the beta-globin gene Gene 2001, 278:131-139. 10.1016/ S0378-1119(01)00716-8 11707330
10. Fu SW Schwartz A Stevenson H Pinzone JJ Davenport GJ Orenstein JM Gutierrez P Simmens SJ Abraham J Poola I Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer Breast Cancer Res 2003, 5:R82-R87. 165014 12817998 10.1186/bcr602
11. Man YG Fu SW Schwartz A Pinzone JJ Simmens SJ Berg PE Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion Breast Cancer Res Treat 2005, 90:241-247. 10.1007/ s10549-004-4492-9 15830137
12. Haga SB Fu S Karp JE Ross DD Williams DM Hankins WD Behm F Ruscetti FW Chang M Smith BD BP1, a new homeobox gene, is frequently expressed in acute leukemias Leukemia 2000, 14:1867-1875. 10.1038/sj.leu.2401912 11069021
13. Zimmermann KC Green DR How cells die: Apoptosis pathways J Allergy Clin Immunol 2001, 108:S99-S103. 10.1067/mai.2001.117819 11586274
14. Kaufmann SH Hengartner MO Programmed cell death: Alive and well in the new millennium Trends Cell Biol 2001, 11:526-534. 10.1016/ S0962-8924(01)02173-0 11719060
15. Li H Zhu H Xu CJ Yuan J Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 1998, 94:491-501. 10.1016/S0092-8674(00)81590-1 9727492
16. Luo X Budihardjo I Zou H Slaughter C Wang X Bid a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 1998, 94:481-490. 10.1016/S0092-8674(00)81589-5 9727491
17. Janicke RU Sprengart ML Wati MR Porter AG Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J Biol Chem 1998, 273:9357-9360. 10.1074/jbc.273.16.9357 9545256
18. Kaufmann SH Vaux DL Alterations in the apoptotic machinery and their potential role in anticancer drug resistance Oncogene 2003, 22:7414-7430. 10.1038/sj.onc.1206945 14576849
19. Seto M Jaeger U Hockett RD Graninger W Bennett S Goldman P Korsemeyer SJ Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma EMBO J 1988, 7:123-131. 454224 2834197
20. Burow ME Weldon CB Tang Y Navar GL Krajewski S Reed JC Hammond TG Clejan S Beckman BS Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants Cancer Res 1998, 58:4940-4946. 9810003
21. Burow ME Weldon CB Tang Y McLachlan JA Beckman BS Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: Subversion of Bcl-2 by anti-oestrogens J Steroid Biochem Mol Biol 2001, 78:409-418. 10.1016/S0960-0760(01)00117-0 11738551
22. Wilson BE Mochon E Boxer LM Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis Mol Cell Biol 1996, 16:5546-5556. 231554 8816467
23. Ebb D Tang DC Dre L Chin K Berg PE Rodgers GP Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment Blood Cells Mol Dis 1998, 24:356-369. 10.1006/bcmd.1998.0202 10087993
24. Johnstone RW Ruefi AA Lowe SW Apoptosis: A link between cancer genetics and chemotherapy Cell 2002, 108:153-164. 10.1016/S0092-8674(02)00625-6 11832206
25. Tuna M Chavez-Reyes A Tari AM HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells Oncogene 2005, 24:1648-1652. 10.1038/sj.onc.1208345 15674342
26. Dong L Wang W Wang F Stoner M Reed JC Harigai M Samudio I Kladde MP Vyhlidal C Safe S Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells J Biol Chem 1999, 274:32099-32107. 10.1074/jbc.274.45.32099 10542244
27. Slee EA Harte MT Kluck RM Wolf BB Casiano CA Newmeyer DD Wang HG Reed JC Nicholson DW Alnemri ES Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner J Cell Biol 1999, 144:281-292. 10.1083/ jcb.144.2.281 9922454
28. Tang D Lahti JM Kidd VJ Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis J Biol Chem 2000, 275:9303-9307. 10.1074/jbc.275.13.9303 10734071
29. Ruiz de Almodovar C Ruiz-Ruiz C Munoz-Pinedo C Robledo G Lopez-Rivas A The differential sensitivity of Bcl-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bcl-2 protein levels Oncogene 2001, 20:7128-7133. 10.1038/sj.onc.1204887 11704839
30. Bieche I de Murcia G Lidereau R Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer Clin Cancer Res 1996, 2:1163-1167. 9816283
31. Virag L Szabo C The therapeutic potential of poly(ADP-ribose) polymerase inhibitors Pharmacol Rev 2002, 54:375-429. 10.1124/pr.54.3.375 12223530
32. Plummer ER Inhibition of poly(ADP-ribsose) polymerase in cancer Curr Opin Pharmacol 2006, 6:364-368. 10.1016/j.coph.2006.02.004 16753340